2435 related articles for article (PubMed ID: 24141020)
61. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates.
Teuling E; Ahmed S; Haasdijk E; Demmers J; Steinmetz MO; Akhmanova A; Jaarsma D; Hoogenraad CC
J Neurosci; 2007 Sep; 27(36):9801-15. PubMed ID: 17804640
[TBL] [Abstract][Full Text] [Related]
62. Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis.
Prause J; Goswami A; Katona I; Roos A; Schnizler M; Bushuven E; Dreier A; Buchkremer S; Johann S; Beyer C; Deschauer M; Troost D; Weis J
Hum Mol Genet; 2013 Apr; 22(8):1581-600. PubMed ID: 23314020
[TBL] [Abstract][Full Text] [Related]
63. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
[TBL] [Abstract][Full Text] [Related]
64. Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis.
Couly S; Khalil B; Viguier V; Roussel J; Maurice T; Liévens JC
Hum Mol Genet; 2020 Mar; 29(4):529-540. PubMed ID: 31696229
[TBL] [Abstract][Full Text] [Related]
65. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Petri S; Chen J; Calingasan NY; Beal MF
Neurodegener Dis; 2005; 2(5):246-54. PubMed ID: 16909005
[TBL] [Abstract][Full Text] [Related]
66. Genetic transfer of the wobbler gene to a C57BL/6J x NZB hybrid stock: natural history of the motor neuron disease and response to CNTF and BDNF cotreatment.
Ishiyama T; Klinkosz B; Pioro EP; Mitsumoto H
Exp Neurol; 1997 Nov; 148(1):247-55. PubMed ID: 9398466
[TBL] [Abstract][Full Text] [Related]
67. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
[TBL] [Abstract][Full Text] [Related]
68. Treatment with Hydrogen-Rich Saline Delays Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis.
Zhang Y; Li H; Yang C; Fan DF; Guo DZ; Hu HJ; Meng XE; Pan SY
Neurochem Res; 2016 Apr; 41(4):770-8. PubMed ID: 26537817
[TBL] [Abstract][Full Text] [Related]
69. Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1
Chiarotto GB; Cartarozzi LP; Perez M; Biscola NP; Spejo AB; Gubert F; França Junior M; Mendez-Otero R; de Oliveira ALR
J Neuroinflammation; 2019 Nov; 16(1):218. PubMed ID: 31727149
[TBL] [Abstract][Full Text] [Related]
70. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
Mancuso R; Del Valle J; Morell M; Pallás M; Osta R; Navarro X
Orphanet J Rare Dis; 2014 May; 9():78. PubMed ID: 24885036
[TBL] [Abstract][Full Text] [Related]
71. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
72. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
Aoki M; Warita H; Suzuki N; Itoyama Y
Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
[TBL] [Abstract][Full Text] [Related]
73. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
74. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis.
Huang G; Lee X; Bian Y; Shao Z; Sheng G; Pepinsky RB; Mi S
Cell Death Dis; 2013 Oct; 4(10):e841. PubMed ID: 24113175
[TBL] [Abstract][Full Text] [Related]
75. Colivelin prolongs survival of an ALS model mouse.
Chiba T; Yamada M; Sasabe J; Terashita K; Aiso S; Matsuoka M; Nishimoto I
Biochem Biophys Res Commun; 2006 May; 343(3):793-8. PubMed ID: 16564029
[TBL] [Abstract][Full Text] [Related]
76. Ablation of interleukin-19 improves motor function in a mouse model of amyotrophic lateral sclerosis.
Komiya H; Takeuchi H; Ogawa Y; Suzuki K; Ogasawara A; Takahashi K; Azuma YT; Doi H; Tanaka F
Mol Brain; 2021 Apr; 14(1):74. PubMed ID: 33931083
[TBL] [Abstract][Full Text] [Related]
77. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
78. ALS-Associated Endoplasmic Reticulum Proteins in Denervated Skeletal Muscle: Implications for Motor Neuron Disease Pathology.
Jesse CM; Bushuven E; Tripathi P; Chandrasekar A; Simon CM; Drepper C; Yamoah A; Dreser A; Katona I; Johann S; Beyer C; Wagner S; Grond M; Nikolin S; Anink J; Troost D; Sendtner M; Goswami A; Weis J
Brain Pathol; 2017 Nov; 27(6):781-794. PubMed ID: 27790792
[TBL] [Abstract][Full Text] [Related]
79. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis.
Almad AA; Doreswamy A; Gross SK; Richard JP; Huo Y; Haughey N; Maragakis NJ
Glia; 2016 Jul; 64(7):1154-69. PubMed ID: 27083773
[TBL] [Abstract][Full Text] [Related]
80. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
